In addition, there were significant differences in the expression of ALKBH7 among different immune and molecular subtypes of breast cancer (BRCA), prostate adenocarcinoma (PRAD), and uterine corpus endometrial carcinoma (UCEC) (45), suggesting that ALKBH7 may play a role in tumor growth and development. This evidence concerns the gene ALKBH7 and prostate adenocarcinoma.